Clinical Trial Update: A Study of AK112 With or Without AK117 in Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial from Akeso is evaluating AK112 with or without AK117 in metastatic colorectal cancer; the study status is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• AK112
• AK117 (AK117)

Snippet

Sponsor: Akeso | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING